DNA XSONM -28.71%43 EBIT per Share is $-16.60 as of Mar. 2026. GuruFocus rates SONM with a GF Score™ of 43/100 and a GF Value™ of $29.79 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 2,127 Software companies, DNA X ranks better than 88.34% on this metric.
DNA X's EBIT per Share for the
three
months ended in Mar. 2026 was $-3.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-16.60.
During the past 3 years, the average EBIT per Share Growth Rate was 56.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for DNA X's EBIT per Share or its related term are showing as below:
SONM'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -20.1 Med: 60.85 Max: 74.5
Current: 56.3
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of DNA X was 74.50% per year. The lowest was -20.10% per year. And the median was 60.85% per year.
SONM's 3-Year EBIT Growth Rate is ranked better than 88.34% of 2127
companies
in the Software industry
Industry Median: 12.1
vs SONM: 56.30
DNA X's EBIT for the
three
months ended in Mar. 2026 was $-3.80 Mil.
DNA X (NAS:SONM) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
DNA X EBIT per Share Related Terms
DNA X EBIT per Share Historical Data
* Premium members only.
The historical data trend for DNA X's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DNA X (SONM) has a EBIT per Share of $-16.60 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on DNA X and its competitors. According to the industry distribution chart, DNA X ranks #248 out of 2127 companies in the Software industry, placing it in the top 11.7%.
Is DNA X's EBIT per Share too high?
DNA X's current EBIT per Share is $-16.60. Based on the distribution chart, DNA X ranks #248 out of 2127 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, DNA X has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does DNA X's EBIT per Share compare to SDCH and CSAI?
According to the Software industry distribution chart, DNA X ranks #248 out of 2127 companies for EBIT per Share. This places DNA X in the top 12% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Software company?
The median EBIT per Share among Software companies is 12.10, based on 2,127 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on DNA X and its competitors. For the Software industry, the median EBIT per Share is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DNA X's current EBIT per Share is $-16.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DNA X stock overvalued right now?
Based on GuruFocus' analysis, DNA X (SONM) is currently considered Possible Value Trap. The stock's GF Value™ is $29.79, compared to a current price of $3.89 — trading 86.9% below its estimated fair value. The current EBIT per Share is $-16.60. DNA X's overall GF Score™ is 43/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For DNA X (SONM), the current EBIT per Share is $-16.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DNA X (SONM) Overvalued in 2026?
Based on GuruFocus' analysis, DNA X stock appears to be undervalued.
The current stock price of $3.89 is trading 86.9% below its estimated GF Value™ of $29.79.
GuruFocus considers DNA X to be Possible Value Trap.
Key valuation signals for SONM:
EBIT per Share: $-16.60
GF Value™: $29.79 vs. price of $3.89 (86.9% below fair value)
No single metric tells the full story. See the SONM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
43GF Score
Get the complete analysis for SONM
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SONM has been successfully added to your 
